Andrew Shindler is a Partner in the London office of Locke Lord LLP. Andrew is a key member of the firm’s Pharmaceutical & Biotech, Privacy & Cybersecurity, Intellectual Property, International Licensing & Technology and Cards & Payments groups.
Andrew has a broad range of experience working in commercial, technology, intellectual property and data protection law within all major sectors, with a particular focus on the life sciences, IT, digital commerce, data, payments, consumer and leisure, and hospitality sectors.
Andrew has some 30 years’ experience in these areas and frequently represents clients on their outsourcing, procurement, research and development, licensing, distribution, merchandising, supply, services, manufacturing, agency and data protection arrangements. Andrew also advises on intellectual property, IT, licensing, contract and data privacy issues associated with M&A and other corporate transactions, such as joint ventures, investments and flotations.
Andrew’s practice focuses on drafting and negotiating contracts, ranging from high value, sophisticated technology agreements to consumer-friendly website terms and conditions. His work covers subject-matter ranging from ophthalmology to cybersecurity. Andrew also advises on all areas of law relevant to the above.
Andrew Shindler is a Partner in the London office of Locke Lord LLP. Andrew is a key member of the firm’s Pharmaceutical & Biotech, Privacy & Cybersecurity, Intellectual Property, International Licensing & Technology and Cards & Payments groups.
Andrew has a broad range of experience working in commercial, technology, intellectual property and data protection law within all major sectors, with a particular focus on the life sciences, IT, digital commerce, data, payments, consumer and leisure, and hospitality sectors.
Andrew has some 30 years’ experience in these areas and frequently represents clients on their outsourcing, procurement, research and development, licensing, distribution, merchandising, supply, services, manufacturing, agency and data protection arrangements. Andrew also advises on intellectual property, IT, licensing, contract and data privacy issues associated with M&A and other corporate transactions, such as joint ventures, investments and flotations.
Andrew’s practice focuses on drafting and negotiating contracts, ranging from high value, sophisticated technology agreements to consumer-friendly website terms and conditions. His work covers subject-matter ranging from ophthalmology to cybersecurity. Andrew also advises on all areas of law relevant to the above.
Andrew has regularly been rated in leading legal directories, such as the Legal 500 and Chambers in a number of disciplines, including pharmaceuticals and life sciences, commercial contracts, IT and non-contentious IP.
Andrew has worked on some of the leading commercial transactions in the City in recent years across a variety of sectors, including life sciences, payments, music, nuclear energy, sport and outsourcing.
Andrew led the teams which won Commercial Law Firm of the Year at the British Legal Awards in 2013 and the commercial team within the winning Corporate Team of the Year – Mid Market at the British Lawyer Awards in 2007.
Representative Experience
- Universal Music on its separation of the Parlophone Label Group and sale to Warner Music for £487 million
- All UK clearing banks on the implementation of CHIP and PIN, Faster Payments and PayM
- Logica on its €300 million fuel card outsourcing arrangements with Shell across 35 countries and sub-contracting arrangements with FleetCor and its outsourcings of its own desktop and laptops
- Numerous European biopharma companies, on international licence/option arrangements for the development and marketing of life-saving medicines, with many of the world’s leading pharma, such as Nicox’s exclusive licences to Pfizer, Merck, Astra-Zeneca and Bausch + Lomb
- Multinational pharma companies on licensing, corporate transactions and distribution arrangements, such as Takeda on its acquisition of licensed rights in Prostrap from Wyeth and Watson on its acquisition of Uteron Pharma
- Denmark Square on the establishment of its crowd funding website Money & Co
- Major UK real estate companies on their procurement of a range of services for commercial tenants
- The Expedia Group on lodging contracts with hotel chains
- Liverpool Football Club on its kit deal with Warrior
- Agreements underlying the entire e-commerce offering of retailers, such as OneSwoop and Jane Norman
- The supplier of food and beverage services on the outsourcing of flight catering for many of the world’s leading airlines
- Mansion Gibraltar on its Premier League shirt sponsorship deal with Tottenham Hotspur FC
- Payments UK, UK Cards, Financial Fraud Action and Asset Backed Finance Association on their merger into UK Finance
- Agalimmune and its investors on its sale to Bioline Rx of Israel
- Merchant Equity Partners on its award winning acquisition of the retail business of MFI
- China General Nuclear on its IP arrangements with EDF in relation to the design and build of nuclear plants in the UK
- All major constituents of the UK cinema industry on its “Orange Wednesday” promotion
- Metabolic Explorer on the sale of its L-Methionine Assets to Evonik of Germany
Professional History
- Partner, Locke Lord (UK) LLP
- Consultant, KWM Europe LLP (January - July 2017)
- Partner, Head of Technology, SJ Berwin LLP, subsequently re-named King & Wood Mallesons LLP (1997 - 2017)
- Senior Solicitor, SJ Berwin LLP (1995 - 1997)
- Visiting Attorney, Baker & Hostetler, Cleveland, Ohio and Washington D.C. (1994 - 1995)
- Solicitor, SJ Berwin & Co (1990 - 1994)
- Trainee Solicitor, SJ Berwin & Co (1987 - 1989)
- Admitted as a Solicitor in England and Wales (1989)
Professional Affiliations and Recognitions
- Member, LESI (Licensing Executives Society International)
- Society of Computers and Law
- City of London Law Society, Commercial Law Committee
- Associate Member, American Bar Association
- Trustee, Cardiovascular Research Trust
Publications and Presentations
- Numerous publications between 1985 ("Derogation From Grant in Copyright Law," Modern Law Review" and "Arbitration Still Bound," Law Quarterly Review) and 2017 on a range of commercial law, IT, intellectual property, technology, life science, data and related topics